companydata.dkcompanydata.dk

LICA PHARMACEUTICALS ApS: Financial statements 2017

CVR: 25332520

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 408,690 and a net result of DKK 812,469 compared with DKK 327,524 the year before. That is a decrease of 44.6% compared with the year before. Equity in the 2017 report amounted to DKK 12,795,456. The solvency ratio was 99.2%.

Gross Profit
DKK 408,690
Profit/Loss
DKK 812,469
Equity
DKK 12,795,456
Total Assets
DKK 12,897,633

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-409 t.812 t.12.8 mio.-
2016-738 t.328 t.12 mio.-
2015-312 t.-2.3 mio.11.7 mio.-
2014-269 t.3.9 mio.13.9 mio.-
2013-341 t.783 t.10 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on LICA PHARMACEUTICALS ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

LICA PHARMACEUTICALS ApS: The 2016 annual report is outMay 5, 2017

LICA PHARMACEUTICALS ApS has published its annual report for 2016. Gross profit came to DKK 737,979, and the net result was DKK 327,524.

About LICA PHARMACEUTICALS ApS

LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The company has 1 employee (2013). In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity in the 2025 report amounted to DKK 24,221,286.

Source: annual report 2025, Danish Business Authority